CD8A and neoplasm: The presence of intratumoral infiltrating PD-1high CD8+ T cells and their subsequent expansion upon PD-1/PD-L1 blockade predicts the effective tumor regression, suggesting the direct role of anti-tumor T cell responses in immunotherapy strategies that target the PD-1/PD-L1 axis [21,52].